Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users
- PMID: 9402078
- DOI: 10.1097/00042560-199712010-00012
Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users
Abstract
Nasal colonization plays an important role in the pathogenesis of Staphylococcus aureus infections. To identify characteristics associated with colonization, we studied a cross-section of a well-described cohort of HIV-seropositive and -seronegative active and former drug users considered at risk for staphylococcal infections. Sixty percent of the 217 subjects were Hispanic, 36% were women, 25% actively used injection drugs, 23% actively used inhalational drugs, 23% received antibiotics, and 35% were HIV-seropositive. Forty-one percent of subjects had positive nasal cultures for S. aureus. The antibiotic susceptibility patterns were similar to the local hospital's outpatient isolates and no dominant strain was identified by arbitrarily primed polymerase chain reaction (AB-PCR). Variables significantly and independently associated with colonization included antibiotic use (odds ratio [OR] = 0.37; confidence interval [CI] = 0.18-0.77), active inhalational drug use within the HIV-seropositive population (OR = 2.36; CI = 1.10-5.10) and female gender (OR = 1.97; CI = 1.09-3.57). Characteristics not independently associated included injection drug use, HIV status, and CD4 count. The association with active inhalational drug use, a novel finding, may reflect alterations in the integrity of the nasal mucosa. The lack of association between HIV infection and S. aureus colonization, which is contrary to most previous studies, could be explained by our rigorous control for confounding variables or by a limited statistical power due to the sample sizes.
Similar articles
-
Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users.Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):463-9. doi: 10.1007/s10096-003-0969-4. Epub 2003 Jul 18. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12884066
-
Risk factors for nasal carriage of Staphylococcus aureus in infectious disease patients, including patients infected with HIV, and molecular typing of colonizing strains.Eur J Clin Microbiol Infect Dis. 2002 Feb;21(2):88-96. doi: 10.1007/s10096-001-0666-0. Eur J Clin Microbiol Infect Dis. 2002. PMID: 11939405
-
Incidence and persistence of Staphylococcus aureus nasal colonization in a community sample of HIV-infected and -uninfected drug users.Clin Infect Dis. 2007 Aug 1;45(3):343-6. doi: 10.1086/519429. Epub 2007 Jun 19. Clin Infect Dis. 2007. PMID: 17599312
-
New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage.Ann Pharmacother. 1998 Jan;32(1):S7-16. doi: 10.1177/106002809803200104. Ann Pharmacother. 1998. PMID: 9475834 Review.
-
Tackling the anterior nares and other sites of colonization: implications for the dermatologist.Cutis. 2007 Jun;79(6 Suppl):52-9. Cutis. 2007. PMID: 17649858 Review.
Cited by
-
Expansion of Microbial Forensics.J Clin Microbiol. 2016 Aug;54(8):1964-74. doi: 10.1128/JCM.00046-16. Epub 2016 Feb 24. J Clin Microbiol. 2016. PMID: 26912746 Free PMC article. Review.
-
Cutaneous microenvironment of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative individuals, with special reference to Staphylococcus aureus colonization.J Clin Microbiol. 2000 Sep;38(9):3174-8. doi: 10.1128/JCM.38.9.3174-3178.2000. J Clin Microbiol. 2000. PMID: 10970352 Free PMC article.
-
Prevalence and behavioural risk factors of Staphylococcus aureus nasal colonization in community-based injection drug users.Epidemiol Infect. 2015 Aug;143(11):2430-9. doi: 10.1017/S0950268814003227. Epub 2014 Dec 1. Epidemiol Infect. 2015. PMID: 25434806 Free PMC article.
-
Community-associated methicillin-resistant Staphylococcus aureus in the patient with HIV infection.Curr HIV/AIDS Rep. 2006 Sep;3(3):107-12. doi: 10.1007/BF02696653. Curr HIV/AIDS Rep. 2006. PMID: 16970836 Review.
-
Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users.Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):463-9. doi: 10.1007/s10096-003-0969-4. Epub 2003 Jul 18. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12884066
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials